These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38781891)

  • 21. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT.
    Santer M; Lawrence M; Pyne S; Renz S; Stuart BL; Sach T; Ridd M; Thomas KS; Nuttall J; Permyakova N; Eminton Z; Francis N; Little P; Muller I; Soulsby I; Thomas K; Griffiths G; Layton AM
    Health Technol Assess; 2024 Sep; 28(56):1-86. PubMed ID: 39268864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do we know about prescribing spironolactone for acne?
    Santer M; Layton A
    BMJ; 2023 May; 381():1114. PubMed ID: 37197774
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse effects of spironolactone therapy in women with acne.
    Lubbos HG; Hasinski S; Rose LI; Pollock J
    Arch Dermatol; 1998 Sep; 134(9):1162-3. PubMed ID: 9762041
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating Acne in Adult Women.
    Harper JC; Stein Gold LF; Alexis AF; Tan JKL
    Semin Cutan Med Surg; 2018 Jun; 37(3S):S67-S70. PubMed ID: 30192345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
    Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
    Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update and future of hormonal therapy in acne.
    Thiboutot D; Chen W
    Dermatology; 2003; 206(1):57-67. PubMed ID: 12566806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 28. Spironolactone in adolescent acne vulgaris.
    Dhurat R; Shukla D; Lim RK; Wambier CG; Goren A
    Dermatol Ther; 2021 Jan; 34(1):e14680. PubMed ID: 33326148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
    Barbieri JS; Choi JK; James WD; Margolis DJ
    J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
    [No Abstract]   [Full Text] [Related]  

  • 30. Spironolactone and cimetidine in treatment of acne.
    Hatwal A; Bhatt RP; Agrawal JK; Singh G; Bajpai HS
    Acta Derm Venereol; 1988; 68(1):84-7. PubMed ID: 2449021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spironolactone in the treatment of adolescent acne: A retrospective review.
    Berman HS; Cheng CE; Hogeling M
    J Am Acad Dermatol; 2021 Jul; 85(1):269-271. PubMed ID: 33253846
    [No Abstract]   [Full Text] [Related]  

  • 32. Spironolactone for acne in women.
    Drug Ther Bull; 2023 Sep; 61(9):132. PubMed ID: 37468231
    [No Abstract]   [Full Text] [Related]  

  • 33. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.
    Barbieri JS; Margolis DJ; Mostaghimi A
    JAMA Dermatol; 2021 Mar; 157(3):296-300. PubMed ID: 33502462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial.
    Kelidari HR; Saeedi M; Hajheydari Z; Akbari J; Morteza-Semnani K; Akhtari J; Valizadeh H; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Oct; 146():47-53. PubMed ID: 27248464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose spironolactone for acne in patients with polycystic ovarian syndrome: A single-institution retrospective study.
    Basu P; Elman SA; Abudu B; Beckles A; Salian P; Yanes DA; Porter ML; Reynolds RV
    J Am Acad Dermatol; 2021 Sep; 85(3):740-741. PubMed ID: 31400460
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral spironolactone improves acne vulgaris and reduces sebum excretion.
    Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P
    Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral spironolactone: an effective treatment for acne vulgaris in women.
    Muhlemann MF; Carter GD; Cream JJ; Wise P
    Br J Dermatol; 1986 Aug; 115(2):227-32. PubMed ID: 2943311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
    Burke BM; Cunliffe WJ
    Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.